Significant effect of high-resolution HLA-DRB1 matching in high-risk corneal transplantation

Transplantation

Volumn 62, Issue 9, 1996, Pages 1273-1277

  Baggesen, Kirsten ^a   Lamm, Lars U ^a   Ehlers, Niels ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA; CORNEA TRANSPLANTATION; DONOR; FEMALE; GRAFT SURVIVAL; HLA MATCHING; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CORNEAL TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 0030473642     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199611150-00017     Document Type: Article

References (26)

1. Ehlers N, Kissmeyer-Nielsen F. Corneal transplantation and HLA histocompatibility. Acta Ophthalmol 1979; 57: 738.
2. Gibbs DC, Batchelor JR, Werb A, Schlesinger W, Casey TA. The influence of tissue-type compatibility on the fate of full-thickness cornea grafts. Trans Ophthalmol Soc UK 1974; 1: 213.
3. Völker-Dieben HJ, Kok-van Alphen CC, Lansbergen Q, Persijn GG. The effect of prospective HLA-A and -B matching on cornea graft survival. Acta Ophthalmol 1982; 61: 203.
4. Sanfilippo F, MacQueen JM, Vaughn WK, Foulks GN. Reduced graft rejection with good HLA-A and -B matching in high-risk corneal transplantation. N Engl J Med 1986; 315: 29.
5. Boisjoly HM, Roy R, Bernard P-M, Dubé I, Laughrea PA, Bazin R. Association between corneal allograft reactions and HLA compatibility. Ophthalmology 1990; 12: 1689.
6. The Collaborative Corneal Transplantation Studies Research Group. The Collaborative Corneal Transplantation Studies (CCTS): effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol 1992; 110: 1392.
7. D'Amaro J, Völker-Dieben H, Kruit PJ, Pels E, de Lange P, Scipper R. HLA matching and other factors in corneal transplantation: a single-centre experience with more than 1800 consecutive transplants in 15 years. Report from 11th Workshop of Histocompatibility Testing. Japan, 1991.
8. Hoffmann F, von Keyserlingk H-J, Wiederholt M. Importance of HLA DR matching for corneal transplantation in high-risk cases. Cornea 1986; 3: 139.
9. Bradley BA, Vail A, Gore SM, et al. Negative effect of HLA-DR matching of corneal transplant rejection. Transplant Proc 1995; 27: 1392.
10. Vail A, Gore SM, Bradley BA, Easty DL, Rogers CA, Armitage WJ. Influence of donor and histocompatibility factors on corneal graft outcome. Transplantation 1994; 58: 1210.
11. Baggesen K, Ehlers N, Lamm LU. HLA-DR/RFLP compatible corneal grafts. Acta Ophthalmol 1991; 69: 229.
12. Andersen J, Ehlers N. Corneal transplantation using long-term cultured donor material. Acta Ophthalmol 1986; 64: 93.
13. Riisom K, Ehlers N, Lamm LU. Post mortem HLA-DR typing of donor corneas using DNA-hybridization technique. Acta Ophthalmol 1987; 65: 430.
14. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantations. Tissue Antigens 1992; 39: 225.
15. Jinks DC, Minter M, Tarver DA, Vanderford M, Hejtmancik JF, McCabe ERB. Molecular genetic diagnosis of sickle cell disease using dried blood specimens on blotters used for newborn screening. Hum Genet 1989; 81: 363.
16. Bidwell JL, Bidwell EA, Savage DA, Middleton D, Klouda PT, Bradley BA. A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10. Transplantation 1988; 3: 640.
17. Bodmer JG, Marsh SGE, Albert ED, et al. Nomenclature for factors of the HLA system, 1994. Eur J Immunogenet 1994; 21: 485.
18. Olerup O, Zetterquist H. HLA-DRB1*01 subtyping by allele-specific PCR amplification: a sensitive, specific and rapid technique. Tissue Antigens 1991; 37: 197.
19. Zetterquist H, Olerup O. Identification of the HLA-DRB1*04,-DRB1*07 and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol 1992; 34: 64.
20. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1.
21. Mytilineos J, Scherer S, Hansen B, Gaweco A, Opelz G. RFLP-DR beta and serological HLA-DR typing of 200 kidney recipients and 1000 controls. Transplant Proc 1990; 4: 1911.
22. Ross J, Callahan D, Kunz H, Niederkorn J. Evidence that the fate of class II-disparate corneal grafts is determined by the timing of class II expression. Transplantation 1991; 51: 532.
23. Treseler P, Foulks G, Sanfillipo F. The expression of HLA antigens by cells in the human cornea. Am J Ophthalmol 1984; 98: 763.
24. Whitsett CF, Stulting RD. The distribution of HLA antigens in human corneal tissue. Invest Ophthalmol Vis Sci 1984; 25: 519.
25. Fujikawa LS, Colvin RB, Bhan AK, Fuller TC, Foster CS. Expression of HLA-A/B/C and -DR locus antigens on epithelial, stromal and endothelial cells of the human cornea. Cornea 1982; 1: 213.
26. Pepose JS, Gardner KM, Nestor MS, Foos RY, Petit TH. Detection of HLA class I and II antigens in rejected human corneal allografts. Ophthalmology 1985; 11: 1480.